This is the authors' abstract. We don't add key points for this paper.
Summary Familial occurrence of myelodysplasia (MDS) and/or acute myeloid leukaemia (AML) is rare but can provide a useful resource for the investigation of predisposing mutations in these myeloid malignancies. To date, examination of families with MDS/AML has lead to the detection of two culprit genes, RUNX1 and CEBPA . Germline mutations in RUNX1 result in familial platelet disorder with propensity to myeloid malignancy and inherited mutations of CEBPA predispose to AML. Unfortunately, the genetic cause remains obscure in most other reported pedigrees. Further insight into the molecular mechanisms of familial MDS/AML will require awareness by clinicians of new patients with relevant family histories.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Owen et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: